These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the thought of focusing on ACKR3 as a novel strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant Conditions. As well as https://jackf603fdz4.blogdosaga.com/profile